Group 1 - The company, Zhengzhou Antu Bioengineering Co., Ltd., announced an investor briefing to discuss its 2024 annual report and Q1 2025 report, aiming to provide a comprehensive understanding of its operational results and financial status [1][2] - The investor briefing will be held on May 19, 2025, from 15:00 to 17:00, utilizing a video and online interactive format [1][3] - Key participants in the briefing will include the company's chairman, financial director, board secretary, and an independent director [1] Group 2 - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center online on the scheduled date [2] - A pre-collection of questions from investors will be available from May 12 to May 16, 2025, allowing them to submit inquiries via the Roadshow Center or the company's email [2] - After the briefing, the main content and proceedings will be accessible on the Shanghai Stock Exchange Roadshow Center [2][3]
安图生物: 安图生物关于召开2024年度暨2025年第一季度业绩说明会的公告